首页> 外文期刊>Case Reports in Dermatological Medicine >Acitretin Treatment for Lipoid Proteinosis
【24h】

Acitretin Treatment for Lipoid Proteinosis

机译:阿维A治疗类脂蛋白沉着症

获取原文
           

摘要

Lipoid proteinosis (LP) is a rare, autosomal-recessive disease characterized by the hoarseness and widespread cutaneous scarring, more prominent on sun-exposed areas. Yellow-white plaques can be seen on oral mucosa and on the skin among depressed scars. Histological evaluation of the affected sites shows accumulation of hyaline-like material in dermis and disruption of basement membrane. Although LP is compatible with normal life expectancy, involvement of upper respiratory tract may endanger patient's life, especially in the case of a respiratory tract infection. Involvement of central nervous system has also been reported, but its clinical importance is obscure. Due to the rarity of LP, a definite therapeutical approach is not established. In this paper we describe a 21-year-old LP patient who was treated with acitretin for six months. Although the outcome with cutaneous lesions was not satisfactory, her hoarseness was significantly improved.
机译:类脂蛋白沉积症(LP)是一种罕见的常染色体隐性遗传疾病,其特征在于声音嘶哑和广泛的皮肤瘢痕形成,在阳光照射区域更为突出。在口腔粘膜和凹陷的疤痕中的皮肤上可以看到黄白色的斑块。受影响部位的组织学评估显示,透明质样物质在真皮中积聚,基底膜破裂。尽管LP与正常预期寿命相符,但上呼吸道受累可能危及患者生命,尤其是在呼吸道感染的情况下。也有中枢神经系统受累的报道,但其临床重要性尚不清楚。由于LP的稀有性,尚未建立明确的治疗方法。在本文中,我们描述了一位21岁的LP患者,他接受了阿维A治疗六个月。尽管皮肤病变的结果并不令人满意,但她的声音嘶哑明显改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号